Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
neuroConn is a leading German medical technology company specializing in advanced neurotechnology for research and clinical applications. The company is globally recognized for its DC-STIMULATOR product line, which provides non-invasive brain stimulation through transcranial direct current (tDCS), alternating current (tACS), and random noise stimulation (tRNS). In addition to stimulation devices, neuroConn develops high-performance EEG amplifiers and integrated systems for neurofeedback and biofeedback. As a core technology brand within the neuroCare Group, neuroConn's products are essential tools in the study and treatment of neurological and psychiatric disorders. Their technology is widely utilized in academic research and is increasingly integrated into clinical workflows for conditions like depression and chronic pain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuroconn.